These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11899518)

  • 1. [The debate on glitazones].
    Lindberg M
    Ugeskr Laeger; 2002 Feb; 164(9):1233-4. PubMed ID: 11899518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glitazones--a new therapeutic principle in diabetes].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2617-9. PubMed ID: 11668762
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 2 diabetes--new treatment].
    Lervang HH
    Ugeskr Laeger; 2001 Oct; 163(44):6101. PubMed ID: 11715150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].
    Gale EA
    Ugeskr Laeger; 2001 Dec; 163(50):7032-5. PubMed ID: 11794032
    [No Abstract]   [Full Text] [Related]  

  • 5. Are thiazolidinediones first-line agents?
    Weldy DL
    J Fam Pract; 2002 Nov; 51(11):984; author reply 984. PubMed ID: 12485560
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiazolidinediones--a means to endpoint intervention.
    Jerkins TW
    Tenn Med; 2000 Nov; 93(11):403-5. PubMed ID: 11077884
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination agents for diabetes.
    Samuel J; Rochester CD
    Adv Nurse Pract; 2003 Jun; 11(6):22-4. PubMed ID: 12807051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
    MMW Fortschr Med; 2002 May; 144(21):53. PubMed ID: 12134428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
    MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
    [No Abstract]   [Full Text] [Related]  

  • 10. Should we now ADOPT glitazones earlier in treatment of type 2 diabetes?
    Howat I; Cleland SJ
    Int J Clin Pract; 2007 Jul; 61(7):1071-3. PubMed ID: 17577291
    [No Abstract]   [Full Text] [Related]  

  • 11. [New oral antidiabetic glitazones].
    Johansen K
    Ugeskr Laeger; 2001 Dec; 164(1):76-7. PubMed ID: 11810811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The failings of NICE. NICE's guidance suggests using rosiglitazone in type 2 diabetes later than is ideal.
    Robinson S; Valabhji J; Schachter M
    BMJ; 2001 Feb; 322(7284):491. PubMed ID: 11222431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is there a need of glitazones in the treatment of diabetes?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Aug; 127(16):2124; author reply 2124. PubMed ID: 17717584
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral antidiabetic drugs in 2003].
    Ducobu J
    Rev Med Brux; 2003 Sep; 24(4):A361-8. PubMed ID: 14606302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are all glitazones the same?
    Van Gaal L; Scheen AJ
    Diabetes Metab Res Rev; 2002; 18 Suppl 2():S1-4. PubMed ID: 11921431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glitazones--again].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2707; author reply 2707. PubMed ID: 17952161
    [No Abstract]   [Full Text] [Related]  

  • 18. [The true place of glitazones in the treatment of diabetes: after the PROactive study].
    Lindberg M; Jørgensen PH; Kampmann JP
    Ugeskr Laeger; 2006 Jun; 168(25):2477-9; author reply 2479-80. PubMed ID: 16824389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glitazones more than hypoglycemics in type 2 diabetes].
    Sjöholm A
    Lakartidningen; 2007 Oct 24-30; 104(43):3201-3. PubMed ID: 18018938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glitazones in type 2 diabetes--documented risks, uncertain benefits].
    Håkansson J
    Lakartidningen; 2007 Oct 24-30; 104(43):3198-200. PubMed ID: 18018937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.